CDEK
← All organizations

Dr. Reddy's Laboratories

For profitContributed to NMEWebsite ↗

Also known as: DR REDDYS | DR REDDYS LA | Dr. Reddy's Laboratories | Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories, Inc | Dr. Reddy's Laboratories Limited | DR. REDDY'S LABORATORIES LIMITED | Dr. Reddys Laboratories, SA | DR REDDYS LABS EU | DR REDDYS LABS INC | DR REDDYS LABS LTD | DR REDDYS LABS SA | Promius Pharma | PROMIUS PHARMA | Promius Pharma, LLC | PROMIUS PHARMA LLC | REDDYS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Oct 1, 1998

First marketed drug

Jan 1, 1984

First NDA

Oct 27, 1986

Last known activity

May 15, 2026

Timeline

1980s

  1. Jan 1, 1984

    Dr. Reddy's Laboratories— Founded

  2. Dec 28, 1984

    acebutolol— NDA Secondary Org

  3. Oct 27, 1986

    guanfacine— NDA Organization

1990s

  1. Jan 1, 1999

    American Remedies, Ltd— Acquired

2000s

  1. May 6, 2004

    Trigenesis Therapeutics— Acquired

  2. Sep 28, 2005

    Perlecan Pharma Pvt Ltd— Acquired

  3. Feb 17, 2006

    Betapharm Arzneimittel GmbH— Acquired

2010s

  1. Oct 23, 2012

    OctoPlus N.V.— Acquired

  2. Apr 8, 2016

    budesonide— Marketing Organization

  3. May 25, 2016

    Ducere Pharma, LLCDucere Pharma, LLC— Acquired

  4. Sep 18, 2016

    Laboratorios LITAPHAR, S.L.— Acquired

Drugs by trial phase (110 distinct, 239 trials)

Indications

Approved for

Studied for

Marketed drugs (287)

Subsidiaries (7 direct, 7 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Hyderabad, IN Jan 1, 1984
First NDA
Oct 27, 1986
Last known activity
May 15, 2026